Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia.
Harousseau
J L
JL
Department of Hematology, Hotel-Dieu, Nantes, France.
Milpied
N
N
Briere
J
J
Desablens
B
B
Le Prise
P Y
PY
Ifrah
N
N
Gandhour
C
C
Casassus
P
P
D000328:Adult; D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002330:Carmustine / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005047:Etoposide / Q000008:administration & dosage; D005602:France / Q000453:epidemiology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D015993:Life Tables; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced; D015996:Survival Rate
D000677:Amsacrine; D003561:Cytarabine; D005047:Etoposide; D003520:Cyclophosphamide; D002330:Carmustine; C002205:zorubicin; D003630:Daunorubicin